Skip to main content
COLLEGIUM PHARMACEUTICAL, INC logo

COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings

Ticker · COLL ISIN · US19459J1043 LEI · 54930049FXZMTLW8D496 US Manufacturing
Open in API
Filings indexed 821 across all filing types
Latest filing 2019-10-31 Regulatory Filings
Country US United States of America
Listing US COLL

About COLLEGIUM PHARMACEUTICAL, INC

https://www.collegiumpharma.com/

Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The provided document text appears to be an encoded or corrupted file content rather than a readable financial or corporate filing document. There are no discernible keywords, regulatory references, report titles, or fiscal period dates that would allow classification into any specific filing category. The text does not contain any clear financial data, management discussion, voting results, or other typical content of known filing types. Given the lack of meaningful content and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which serves as a catch-all category for filings that do not fit other specific types.
2019-10-31 English
S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used by companies to register securities for public offering under the Securities Act of 1933. It includes detailed information about the types of securities to be offered (common stock, preferred stock, debt securities, warrants), the maximum aggregate offering price, and the registration fee calculation. The document is a regulatory filing related to capital raising but is not an earnings release, annual report, or other financial report. It is a primary registration statement for securities issuance, which fits the definition of a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement, not just an announcement or notice, so it is not an RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2019-10-25 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-18 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-04 English
PRIMARY DOCUMENT
Director's Dealing
2019-08-13 English
PRIMARY DOCUMENT
Director's Dealing
2019-08-13 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.